An established Northern California professional, Anna Beryozkina, PharmD, serves as an associate clinical scientist with a major biotechnology corporation. Dr. Anna Beryozkina’s core responsibilities include advancing clinical development plans and ensuring their proper execution.

Authoring protocols for clinical trials, Dr. Beryozkina has provided advice on study data and analytical strategies with a particular focus on meeting documentation requirements associated with regulatory filings. These span applicable laws and organizational standards for product submissions. She also conducts clinical data reviews as required and ensures that protocol and clinical results match.

Active in her professional community, Dr. Anna Beryozkina regularly attends meetings of the American College of Rheumatology and the American Society of Clinical Oncology. This reflects her particular interest in and knowledge of drug development in the areas of rheumatoid arthritis and cancer.

An alumna of Massachusetts College of Pharmacy and Health Sciences, Dr. Beryozkina completed post-doctoral fellowships in clinical pharmacology and regulatory affairs program management through a partnership between Hoffmann-La Roche and Rutgers University.